IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 50 di 285
Titolo Data di pubblicazione Autore(i) File
Treatment of glomerulonephritis in type II mixed cryoglobulinemia with Rituximab 1-gen-2004 DE MARCHI, G.; DE VITA, Salvatore; Esposito, W.; Quartuccio, Luca; Romano, Giulio; Sacco, S.; Soardo, G.
Fibronectin plasma levels and gene polymorphisms in aggressive RA patients treated with anti-TNF-alpha agents. 1-gen-2004 Fabris, M; Tolusso, B; Sacco, S; Quartuccio, Luca; Ferraccioli, G; DE VITA, Salvatore
Fibronectin plasma levels and gene polymorphisms in aggressive RA patients treated with anti-TNF-alpha agents 1-gen-2004 Fabris, M; Tolusso, B; Sacco, S; Quartuccio, Luca; Ferraccioli, G; DE VITA, Salvatore
B lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis 1-gen-2004 Quartuccio, Luca; Fabris, M; Ferraccioli, G.
CICLOSPORINA E TACROLIMUS NELLE MIOSITE DEI CORPI INCLUSI 1-gen-2005 Quartuccio, Luca; DE MARCHI, G; Cavarape, Alessandro; Franzolini, N; Moroldo, T; Perin, A; Ferraccioli, Gf; DE VITA, Salvatore
Ciclosporina e tacrolimus nella miosite da corpi inclusi: efficacia clinica, sicurezza e risparmio nell'uso dei corticosteroidi 1-gen-2005 Quartuccio, Luca; De Marchi, G; Cavarape, Alessandro; Franzolini, N; Moroldo, T; Perin, A; Ferraccioli, Gf; DE VITA, Salvatore
B-Lymphocyte Stimulator (BLyS) in mixed cryoglobulinemia sindrome: pathobiological and clinical implication 1-gen-2005 Fabris, M; Sacco, S; De Marchi, G; Quartuccio, Luca; Migone, T; Pozzato, G; Mazzaro, C; Ferraccioli, G; DE VITA, Salvatore
B-Lymphocyte Stimulator (BLyS) in mixed cryoglobulinemia sindrome: pathobiological and clinical implication. 1-gen-2005 Fabris, M; Sacco, S; De Marchi, G; Quartuccio, Luca; Migone, T; Pozzato, G; Mazzaro, C; Ferraccioli, G; DE VITA, Salvatore
Transverse myelitis in primary Sjögren's syndrome: usefulness of low-dose oral cyclophosphamide rather than pulse therapy. 1-gen-2006 Quartuccio, Luca; Ferraccioli, Gf; DE VITA, Salvatore
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization. 1-gen-2006 Quartuccio, Luca; De Re, V.; Fabris, M; Marzotto, A.; Franzolini, N; Gasparotto, D.; Caggiari, L.; Ferraccioli, G.; Scott, Cathryn Anne; DE VITA, Salvatore
Treatment of rheumatoid arthritis with rituximab: an update and possible indications. 1-gen-2006 DE VITA, Salvatore; Quartuccio, Luca
Efficacy of cyclosporin-A in the long-term management of thrombocytopenia associated with systemic lupus erythematosus 1-gen-2006 Quartuccio, Luca; Sacco, S; Franzolini, N; Perin, A; Ferraccioli, G; DE VITA, Salvatore
Rituximab as possible first-line therapy for glomerulonephritis in HCV-related mixed cryoglobulinaemia 1-gen-2006 DE VITA, Salvatore; Quartuccio, Luca
Rituximab treatment for Glomerulonephritis in HCV-associated Mixed Cryoglobulinemia: efficacy and safety in the lack of steroids 1-gen-2006 Quartuccio, Luca; Soardo, G; Romano, Giulio; Zaja, F; Scott, Cathryn Anne; DE MARCHI, G; Fabris, M; Ferraccioli, G; DE VITA, Salvatore
Association be tween B cell clonal expansion and glomerulonephritis in type cryoglobulinnaemia. 2007; 66 (Suppl. II): 121 1-gen-2007 Quartuccio, Luca; Fabris, M; De Marchi, G; Salvin, S; Falleti, E; DE VITA, Salvatore
Evidence for an association between the -871 t/c promoter polymorphism in the b-lymphocyte stimulator (blys) gene and the development of an overt lymphoproliferative disorder in mixed cryoglobulinemia syndrome (mcsn) 1-gen-2007 Fabris, M; Lerussi, A; Quartuccio, Luca; De, Marchi; DE VITA, Salvatore
Interleukin 1 receptor antagonist therapy-induced thrombocytopenia in adult onset Still's disease 1-gen-2007 Quartuccio, Luca; DE VITA, Salvatore
Development of type II mixed cryoglobulinaemic syndrome after effective and persistent hepatitis C virus eradication. 1-gen-2007 Quartuccio, Luca; De Marchi, G.; Fabris, M.; DE VITA, Salvatore
POSITIVIZZIONE TARDIVA DELL'ANGIOGRAFIA CELEBRALE IN UN CASO DI VASCULITE CELEBRALE PRIMITIVA 1-gen-2007 Quartuccio, Luca; Tuniz, F; Petralia, B; Canotti, B; Skrap, M; DE VITA, Salvatore
B-Lymphocyte Stimulator (BLyS) upregulation in mixed cryoglobulinemia syndrome and hepatitis C virus infection 1-gen-2007 Fabris, M.; Quartuccio, Luca; Sacco, S.; De Marchi, G.; Pozzato, G.; Mazzaro, C.; Ferraccioli, G.; Migone, T.; DE VITA, Salvatore
Bone marrow B-cell clonal expansion in type II mixed cryoglobulinaemia: Association with nephritis RID A-8026-2008 1-gen-2007 Quartuccio, Luca; Fabris, M; Salvin, S; Isola, Miriam; Soldano, F; Falleti, E; Beltrami, Ca; De Re, V; DE VITA, Salvatore
Association between bone marrow B cell clonal expansion and glomerulonephritis in type II mixed cryoglobulinaemia 1-gen-2007 Quartuccio, Luca; Fabris, M; Sacco, S.
Association be tween B cell clonal expansion and glomerulonephritis in type cryoglobulinnaemia 1-gen-2007 Quartuccio, Luca; Fabris, M; De Marchi, G; Salvin, S; Falleti, E; DE VITA, Salvatore
Rituximab in mixed cryoglobulinemia: increased experience and perspectives 1-gen-2007 DE VITA, Salvatore; Quartuccio, Luca; Fabris, M.
Efficacy of ab initio immunosuppressive therapy and steroid-sparing effect in interstitial lung disease associated with antisynthetase antibody syndrome 1-gen-2007 Franzolini, N.; Quartuccio, Luca; De Marchi, G.; DE VITA, Salvatore
Treatment of inclusion body myositis with cyclosporin-A or tacrolimus: successful long-term management in patients with earlier active disease and concomitant autoimmune features- 1-gen-2007 Quartuccio, Luca; DE MARCHI, G; Scott, Cathryn Anne; Ferraccioli, G; Beltrami, Carlo Alberto; DE VITA, Salvatore
Long-term response to rituximab in 36 patents with the reumatoid arthritis: a single centre experience 1-gen-2008 Quartuccio, Luca; Salvin, S; Regis, M; Lombardi, S; Mansutti, E; Maset, M; DE VITA, Salvatore
Long-term response to rituximab in 36 patents with the reumatoid arthritis: a single centre wxperience. 1-gen-2008 Quartuccio, Luca; Salvin, S; Regis, M; Lombardi, S; Mansutti, E; Maset, M; DE VITA, Salvatore
Neurological involvement in undifferentiatied connective tissute disease (UCTDS) 1-gen-2008 Franzolini, N; Quartuccio, Luca; Battellino, M; Venturinip, ; Tomietto, P; Mansutti, E; Sacco, S; Di Benedetto, P; DE VITA, Salvatore
Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia. 1-gen-2008 Baldini, C; DE RE, V; DE VITA, Salvatore; Fabris, M; Ferri, C; Mazzaro, C; Pozzato, G; Quartuccio, Luca; Salvin, S.
Gastrointestinal involvement in systemic vasculitis 1-gen-2008 DE VITA, Salvatore; Quartuccio, Luca; Gremese, E; Ferraccioli, Gf
Rituximab for the Long Term Treatment of Severe Cutaneous Involvement in Systemic Sclerosis 1-gen-2008 Lombardi, S; Quartuccio, Luca; Franzolini, N; Salvin, S; Sacco, S; Di Poi, E; Perin, A; DE VITA, Salvatore
Safety of Rituximab in different rheumatic autoimmune diseases. A single centre experience in 85 cases. 1-gen-2008 Quartuccio, Luca; Fabris, M; Sacco, S; Perin, A; Di Poi, E; DE VITA, Salvatore
Safety of Rituximab in different rheumatic autoimmune diseases. A single centre experience in 85 cases. 2008 1-gen-2008 Quartuccio, Luca; Fabris, M; Sacco, S; Perin, A; Di Poi, E; DE VITA, Salvatore
Disappearance of bone marrow B cell clonal expansion in patients with type II hepatitis C virus-related cryoglobulinemic glomerulonephritis after clinical efficient rituximab therapy. 1-gen-2008 DE VITA, Salvatore; Fabris, M.; Quartuccio, Luca; Sacco, S.; Salvin, S.
Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both? 1-gen-2008 DE VITA, Salvatore; Quartuccio, Luca; Fabris, M.
Resistance to Rituximab Therapy and Local BAFF Overexpression in Sjögren's Syndrome-Related Myoepithelial Sialadenitis and Low-Grade Parotid B-Cell Lymphoma 1-gen-2008 Quartuccio, Luca; Fabris, M; Moretti, M; Barone, F; Bombardieri, M; Rupolo, M; Lombardi, S; Pitzalis, C; Beltrami, Ca; Curcio, Francesco; DE VITA, Salvatore
Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes 1-gen-2008 Fabris, M; Quartuccio, Luca; De Re, V; Pozzato, G; Mazzaro, C; Tavoni, A; Ferri, C; Salvin, S; Lerussi, A; Fabro, C; Bombardieri, S; DE VITA, Salvatore
Rheumatoid factor positivity, a lower disability and a lower number of anti-tnf agents failed are associated with response to rituximab in rheumatoid arthritis 1-gen-2009 Quartuccio, Luca; Salvin, S; Fabris, M; Atzeni, F; Sarzi Puttini, P; Saracco, M; Pellerito, R; Benucci, M; Cimmino, M; Cutolo, M; DE VITA, Salvatore
Rituximab for rheumatoid arthritis refractory to both conventional therapy and anti-tumor necrosis factor therapy: results of a multi-centre observational italian study 1-gen-2009 Atzeni, F; Batticciotto, A; Quartuccio, Luca; DE VITA, Salvatore; Caporali, R; Benucci, M; Manfredi, M; Pellerito, R; Pennetta, S; Gorla, R; Zignoli, T; Covelli, M; Scioscia, C; Macchioni, M; Marchesoni, A; Sarzi puttini, P.
Controversies on rituximab therapy in Sjögren's syndrome-associated lymphoproliferation 1-gen-2009 Quartuccio, Luca; Fabris, M; Salvin, S; Maset, M; De Marchi, G; DE VITA, Salvatore
Strontium ranelate and femural fracture healing during rheumatoid arthritis and osteoporosis 1-gen-2009 Salvin, S; Quartuccio, L; Maset, M; Lombardi, S; Sacco, S; Mansutti, E; De Vita, S
Use of teriparatide in osteoporosis due to active rheumatic diseases 1-gen-2009 Salvin, S; Maset, M; Quartuccio, L; Sacco, S; De Marchi, G; De Vita, S
BlYS Promoter Polymorphins and Response to Rituximab in Rheumatoid Arthritis (RA) patients positive or negative for Rheumatoid Factor, , vol 60 suppl 10 :1678 1-gen-2009 M., Fabris; Quartuccio, Luca; M., Saracco; R., Pellerito; F., Atzeni; P., Scarzi Puttini; M., Cimmino; M., Benucci; C., Fabro; P., Morassi; M., Bolzan; F., Fischetti; DE VITA, Salvatore
Rankl and osteoprotegerin serum levels changes after rituximab therapy in rheumatoid arthritis: correlation with disease control and bone mineral density preservation 1-gen-2009 Fabris, M; Salvin, S; Tonutti, E; Quartuccio, Luca; Lerussi, A; Fabro, C.
prevalence of chlamydophila psittaci subclinical infection in italian patients with rheumatoid arthritis: etiopathological and therapeutic implications 1-gen-2009 Fabris, M; Pasini, E; Lombardi, S; Fabro, C; Bolzan, C; Quartuccio, Luca
Rheumatoid factor positivity, a lower disability and a lower number of anti-tnf agents failed are associated with response to rituximab in rheumatoid arthritis 1-gen-2009 Quartuccio, Luca; S., Salvin; M., Fabris; F., Atzeni; P., Sarzi Puttini; M., Saracco; R., Pellerito; M., Benucci; M., Cimmino; M., Cutolo; DE VITA, Salvatore
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFalpha agents failed are associated with response to rituximab in rheumatoid arthritis 1-gen-2009 Quartuccio, Luca; Salvin, S; Saracco, M; Lombardi, S; Fabris, M; Mansutti, E; Maset, M; Pellerito, S; DE VITA, Salvatore
Blys Promoter Polymorphism And Response To Rituximab In Rheumatoid Arthritis (RA) Patients Positive Or Negative For The Rheumatoid Factor 1-gen-2009 Fabris, M; Quartuccio, Luca; Saracco, M; Pellerito, R; Atzeni, F; Sarzi Puttini, P.
BLYS Promoter Polymorphins and Response to Rituximab in Rheumatoid Arthritis (RA) patients positive or negative for Rheumatoid Facto 1-gen-2009 Fabris, M; Quartuccio, Luca; Saracco, M; Pellerito, R; Atzeni, F; Scarzi Puttini, P.
Mostrati risultati da 1 a 50 di 285
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile